Improved safety monitoring, cooperation with international partners, and enhanced transparency are roadmap objectives of which major government organization? If you guessed the European Medicines Agency... you're right! Maybe that cross-pond cooperation isn't as difficult as it seems. Article
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Comments